UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Two subpopulations of thrombin‐activated platelets differ in their binding of the components of the intrinsic factor X‐activating complex

Journal of thrombosis and haemostasis, 2005-11, Vol.3 (11), p.2545-2553

2005

Volltextzugriff (PDF)

Initiation and propagation of coagulation from tissue factor‐bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate

Journal of thrombosis and haemostasis, 2005-02, Vol.3 (2), p.321-331

2005

Volltextzugriff (PDF)

Molecular basis of haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2004-10, Vol.10 (s4), p.133-139

2004

Volltextzugriff (PDF)

Mathematical models of blood coagulation and platelet adhesion: clinical applications

Current pharmaceutical design, 2007-05, Vol.13 (14), p.1457-1467

2007

Volltextzugriff (PDF)

Strategies towards a longer acting factor VIII

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-07, Vol.12 (s3), p.42-51

2006

Volltextzugriff (PDF)

Heparin resistance

British journal of anaesthesia : BJA, 2002-04, Vol.88 (4), p.467-469

2002

Volltextzugriff (PDF)

Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation : Evidence for nonproteolytic inactivation of factor VIIIa in vivo

Blood, 1999, Vol.93 (1), p.176-183

1999

Volltextzugriff (PDF)

A role for the C2 domain of factor VIII in binding to von Willebrand factor

The Journal of biological chemistry, 1994-04, Vol.269 (15), p.11601-11605

1994

Volltextzugriff (PDF)

Some human inhibitor antibodies interfere with factor VIII binding to factor IX

Blood, 1998-07, Vol.92 (1), p.136-142

1998

Volltextzugriff (PDF)

The future of recombinant coagulation factors

Journal of thrombosis and haemostasis, 2003-05, Vol.1 (5), p.922-930

2003

Volltextzugriff (PDF)

Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain

Thrombosis and haemostasis, 1999-01, Vol.81 (1), p.39-44

1999

Volltextzugriff (PDF)

The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor

The Journal of biological chemistry, 1997-07, Vol.272 (29), p.18007-18014

1997

Volltextzugriff (PDF)

Role of the Low Density Lipoprotein-related Protein Receptor in Mediation of Factor VIII Catabolism

The Journal of biological chemistry, 1999-12, Vol.274 (53), p.37685-37692

1999

Volltextzugriff (PDF)

Human factor VIII can be packaged and functionally expressed in an adeno‐associated virus background: applicability to haemophilia A gene therapy

British journal of haematology, 1999-01, Vol.104 (1), p.27-36

1999

Volltextzugriff (PDF)

Cell Surface Heparan Sulfate Proteoglycans Participate in Factor VIII Catabolism Mediated by Low Density Lipoprotein Receptor-related Protein

The Journal of biological chemistry, 2001-04, Vol.276 (15), p.11970-11979

2001

Volltextzugriff (PDF)

Haemophilia A: effects of inhibitory antibodies on factor VIII functional interactions and approaches to prevent their action

Haemophilia : the official journal of the World Federation of Hemophilia, 2002-01, Vol.8 (1), p.1-11

2002

Volltextzugriff (PDF)

Factor VIII and transmissible spongiform encephalopathy: the case for safety

Haemophilia : the official journal of the World Federation of Hemophilia, 2002-03, Vol.8 (2), p.63-75

2002

Volltextzugriff (PDF)

Molecular defects in coagulation Factor VIII and their impact on Factor VIII function

Vox sanguinis, 2002-08, Vol.83 (2), p.89-96

2002

Volltextzugriff (PDF)

Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitors

Thrombosis and haemostasis, 1998-01, Vol.79 (1), p.62-68

1998

Volltextzugriff (PDF)

Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa

Blood, 2001-02, Vol.97 (3), p.685-691

2001

Volltextzugriff (PDF)

Slowed Release of Thrombin-cleaved Factor VIII from von Willebrand Factor by a Monoclonal and a Human Antibody Is a Novel Mechanism for Factor VIII Inhibition

The Journal of biological chemistry, 1996-11, Vol.271 (44), p.27424-27431

1996

Volltextzugriff (PDF)

An alloantibody recognizing the FVIII A1 domain in a patient with CRM reduced haemophilia A due to deletion of a large portion of the A1 domain DNA sequence

Thrombosis and haemostasis, 2000-09, Vol.84 (3), p.442-448

2000

Volltextzugriff (PDF)

Efficient factor VIII affinity purification using a small synthetic ligand

Journal of thrombosis and haemostasis, 2008-03, Vol.6 (3), p.470-477

2008

Volltextzugriff (PDF)

Effect of von Willebrand Factor and Its Proteolytic Fragments on Kinetics of Interaction between the Light and Heavy Chains of Human Factor VIII

Thrombosis research, 1999-12, Vol.96 (5), p.343-354

1999

Volltextzugriff (PDF)

Factor V C2 domain contains a major thrombin‐binding site responsible for thrombin‐catalyzed factor V activation

Journal of thrombosis and haemostasis, 2006-06, Vol.4 (6), p.1354-1360

2006

Volltextzugriff (PDF)

1 – 25 von 184

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Englisch
(142)
Russisch
(44)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Two subpopulations of thrombin‐activated platelets differ in their binding of the components of the intrinsic factor X‐activating complex

Initiation and propagation of coagulation from tissue factor‐bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate

Molecular basis of haemophilia A

Mathematical models of blood coagulation and platelet adhesion: clinical applications

Strategies towards a longer acting factor VIII

Heparin resistance

Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation : Evidence for nonproteolytic inactivation of factor VIIIa in vivo

A role for the C2 domain of factor VIII in binding to von Willebrand factor

Some human inhibitor antibodies interfere with factor VIII binding to factor IX

The future of recombinant coagulation factors

Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain

The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor

Role of the Low Density Lipoprotein-related Protein Receptor in Mediation of Factor VIII Catabolism

Human factor VIII can be packaged and functionally expressed in an adeno‐associated virus background: applicability to haemophilia A gene therapy

Cell Surface Heparan Sulfate Proteoglycans Participate in Factor VIII Catabolism Mediated by Low Density Lipoprotein Receptor-related Protein

Haemophilia A: effects of inhibitory antibodies on factor VIII functional interactions and approaches to prevent their action

Factor VIII and transmissible spongiform encephalopathy: the case for safety

Molecular defects in coagulation Factor VIII and their impact on Factor VIII function

Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitors

Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa

Slowed Release of Thrombin-cleaved Factor VIII from von Willebrand Factor by a Monoclonal and a Human Antibody Is a Novel Mechanism for Factor VIII Inhibition

An alloantibody recognizing the FVIII A1 domain in a patient with CRM reduced haemophilia A due to deletion of a large portion of the A1 domain DNA sequence

Efficient factor VIII affinity purification using a small synthetic ligand

Effect of von Willebrand Factor and Its Proteolytic Fragments on Kinetics of Interaction between the Light and Heavy Chains of Human Factor VIII

Factor V C2 domain contains a major thrombin‐binding site responsible for thrombin‐catalyzed factor V activation

Suchergebnisse filtern